line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,0.0,GENESYS.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.321406,GENESYS.NS
Normalized EBITDA,2025-03-31 00:00:00,1464844000.0,GENESYS.NS
Total Unusual Items,2025-03-31 00:00:00,,GENESYS.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,,GENESYS.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Reconciled Depreciation,2025-03-31 00:00:00,550279000.0,GENESYS.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,1416237000.0,GENESYS.NS
EBITDA,2025-03-31 00:00:00,1464844000.0,GENESYS.NS
EBIT,2025-03-31 00:00:00,914565000.0,GENESYS.NS
Net Interest Income,2025-03-31 00:00:00,-87803000.0,GENESYS.NS
Interest Expense,2025-03-31 00:00:00,87803000.0,GENESYS.NS
Interest Income,2025-03-31 00:00:00,,GENESYS.NS
Normalized Income,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Total Expenses,2025-03-31 00:00:00,2239306000.0,GENESYS.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,GENESYS.NS
Diluted Average Shares,2025-03-31 00:00:00,40073557.0,GENESYS.NS
Basic Average Shares,2025-03-31 00:00:00,39761810.0,GENESYS.NS
Diluted EPS,2025-03-31 00:00:00,14.03,GENESYS.NS
Basic EPS,2025-03-31 00:00:00,14.14,GENESYS.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Net Income Common Stockholders,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,GENESYS.NS
Net Income,2025-03-31 00:00:00,562232000.0,GENESYS.NS
Minority Interests,2025-03-31 00:00:00,1196000.0,GENESYS.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,561036000.0,GENESYS.NS
Net Income Continuous Operations,2025-03-31 00:00:00,561036000.0,GENESYS.NS
Tax Provision,2025-03-31 00:00:00,265726000.0,GENESYS.NS
Pretax Income,2025-03-31 00:00:00,826762000.0,GENESYS.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,43556000.0,GENESYS.NS
Special Income Charges,2025-03-31 00:00:00,,GENESYS.NS
Other Special Charges,2025-03-31 00:00:00,,GENESYS.NS
Write Off,2025-03-31 00:00:00,,GENESYS.NS
Impairment Of Capital Assets,2025-03-31 00:00:00,,GENESYS.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,-87803000.0,GENESYS.NS
Total Other Finance Cost,2025-03-31 00:00:00,,GENESYS.NS
Interest Expense Non Operating,2025-03-31 00:00:00,87803000.0,GENESYS.NS
Interest Income Non Operating,2025-03-31 00:00:00,,GENESYS.NS
Operating Income,2025-03-31 00:00:00,871009000.0,GENESYS.NS
Operating Expense,2025-03-31 00:00:00,823069000.0,GENESYS.NS
Other Operating Expenses,2025-03-31 00:00:00,272790000.0,GENESYS.NS
Depreciation And Amortization In Income Statement,2025-03-31 00:00:00,550279000.0,GENESYS.NS
Amortization,2025-03-31 00:00:00,,GENESYS.NS
Depreciation Income Statement,2025-03-31 00:00:00,550279000.0,GENESYS.NS
Selling General And Administration,2025-03-31 00:00:00,,GENESYS.NS
General And Administrative Expense,2025-03-31 00:00:00,,GENESYS.NS
Rent And Landing Fees,2025-03-31 00:00:00,,GENESYS.NS
Gross Profit,2025-03-31 00:00:00,1694078000.0,GENESYS.NS
Cost Of Revenue,2025-03-31 00:00:00,1416237000.0,GENESYS.NS
Total Revenue,2025-03-31 00:00:00,3110315000.0,GENESYS.NS
Operating Revenue,2025-03-31 00:00:00,3110315000.0,GENESYS.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,0.0,GENESYS.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,GENESYS.NS
Normalized EBITDA,2024-03-31 00:00:00,855651000.0,GENESYS.NS
Total Unusual Items,2024-03-31 00:00:00,12598000.0,GENESYS.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,12598000.0,GENESYS.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Reconciled Depreciation,2024-03-31 00:00:00,444802000.0,GENESYS.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,993068000.0,GENESYS.NS
EBITDA,2024-03-31 00:00:00,855651000.0,GENESYS.NS
EBIT,2024-03-31 00:00:00,410849000.0,GENESYS.NS
Net Interest Income,2024-03-31 00:00:00,-39094000.0,GENESYS.NS
Interest Expense,2024-03-31 00:00:00,39094000.0,GENESYS.NS
Interest Income,2024-03-31 00:00:00,8758000.0,GENESYS.NS
Normalized Income,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Total Expenses,2024-03-31 00:00:00,1621844000.0,GENESYS.NS
Rent Expense Supplemental,2024-03-31 00:00:00,1244000.0,GENESYS.NS
Diluted Average Shares,2024-03-31 00:00:00,38454530.0,GENESYS.NS
Basic Average Shares,2024-03-31 00:00:00,38188408.0,GENESYS.NS
Diluted EPS,2024-03-31 00:00:00,5.74,GENESYS.NS
Basic EPS,2024-03-31 00:00:00,5.78,GENESYS.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Net Income Common Stockholders,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,GENESYS.NS
Net Income,2024-03-31 00:00:00,220729000.0,GENESYS.NS
Minority Interests,2024-03-31 00:00:00,4606000.0,GENESYS.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,216123000.0,GENESYS.NS
Net Income Continuous Operations,2024-03-31 00:00:00,216123000.0,GENESYS.NS
Tax Provision,2024-03-31 00:00:00,155632000.0,GENESYS.NS
Pretax Income,2024-03-31 00:00:00,371755000.0,GENESYS.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,50264000.0,GENESYS.NS
Special Income Charges,2024-03-31 00:00:00,1551000.0,GENESYS.NS
Other Special Charges,2024-03-31 00:00:00,-1551000.0,GENESYS.NS
Write Off,2024-03-31 00:00:00,0.0,GENESYS.NS
Impairment Of Capital Assets,2024-03-31 00:00:00,,GENESYS.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-39094000.0,GENESYS.NS
Total Other Finance Cost,2024-03-31 00:00:00,6471000.0,GENESYS.NS
Interest Expense Non Operating,2024-03-31 00:00:00,39094000.0,GENESYS.NS
Interest Income Non Operating,2024-03-31 00:00:00,8758000.0,GENESYS.NS
Operating Income,2024-03-31 00:00:00,360585000.0,GENESYS.NS
Operating Expense,2024-03-31 00:00:00,628776000.0,GENESYS.NS
Other Operating Expenses,2024-03-31 00:00:00,183974000.0,GENESYS.NS
Depreciation And Amortization In Income Statement,2024-03-31 00:00:00,444802000.0,GENESYS.NS
Amortization,2024-03-31 00:00:00,219451000.0,GENESYS.NS
Depreciation Income Statement,2024-03-31 00:00:00,444802000.0,GENESYS.NS
Selling General And Administration,2024-03-31 00:00:00,72477000.0,GENESYS.NS
General And Administrative Expense,2024-03-31 00:00:00,72477000.0,GENESYS.NS
Rent And Landing Fees,2024-03-31 00:00:00,1244000.0,GENESYS.NS
Gross Profit,2024-03-31 00:00:00,989361000.0,GENESYS.NS
Cost Of Revenue,2024-03-31 00:00:00,993068000.0,GENESYS.NS
Total Revenue,2024-03-31 00:00:00,1982429000.0,GENESYS.NS
Operating Revenue,2024-03-31 00:00:00,1982429000.0,GENESYS.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,7196700.0,GENESYS.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,GENESYS.NS
Normalized EBITDA,2023-03-31 00:00:00,627926000.0,GENESYS.NS
Total Unusual Items,2023-03-31 00:00:00,23989000.0,GENESYS.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,23989000.0,GENESYS.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,190778000.0,GENESYS.NS
Reconciled Depreciation,2023-03-31 00:00:00,375298000.0,GENESYS.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,960544000.0,GENESYS.NS
EBITDA,2023-03-31 00:00:00,651915000.0,GENESYS.NS
EBIT,2023-03-31 00:00:00,276617000.0,GENESYS.NS
Net Interest Income,2023-03-31 00:00:00,-25544000.0,GENESYS.NS
Interest Expense,2023-03-31 00:00:00,26661000.0,GENESYS.NS
Interest Income,2023-03-31 00:00:00,3841000.0,GENESYS.NS
Normalized Income,2023-03-31 00:00:00,173985700.0,GENESYS.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,190778000.0,GENESYS.NS
Total Expenses,2023-03-31 00:00:00,1595645000.0,GENESYS.NS
Rent Expense Supplemental,2023-03-31 00:00:00,3305000.0,GENESYS.NS
Diluted Average Shares,2023-03-31 00:00:00,36172839.0,GENESYS.NS
Basic Average Shares,2023-03-31 00:00:00,35147151.0,GENESYS.NS
Diluted EPS,2023-03-31 00:00:00,5.29,GENESYS.NS
Basic EPS,2023-03-31 00:00:00,5.44,GENESYS.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,190778000.0,GENESYS.NS
Net Income Common Stockholders,2023-03-31 00:00:00,190778000.0,GENESYS.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,GENESYS.NS
Net Income,2023-03-31 00:00:00,190778000.0,GENESYS.NS
Minority Interests,2023-03-31 00:00:00,41460000.0,GENESYS.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,149318000.0,GENESYS.NS
Net Income Continuous Operations,2023-03-31 00:00:00,149318000.0,GENESYS.NS
Tax Provision,2023-03-31 00:00:00,100638000.0,GENESYS.NS
Pretax Income,2023-03-31 00:00:00,249956000.0,GENESYS.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,4432000.0,GENESYS.NS
Special Income Charges,2023-03-31 00:00:00,-4000.0,GENESYS.NS
Other Special Charges,2023-03-31 00:00:00,-20000.0,GENESYS.NS
Write Off,2023-03-31 00:00:00,24000.0,GENESYS.NS
Impairment Of Capital Assets,2023-03-31 00:00:00,,GENESYS.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-25544000.0,GENESYS.NS
Total Other Finance Cost,2023-03-31 00:00:00,2724000.0,GENESYS.NS
Interest Expense Non Operating,2023-03-31 00:00:00,26661000.0,GENESYS.NS
Interest Income Non Operating,2023-03-31 00:00:00,3841000.0,GENESYS.NS
Operating Income,2023-03-31 00:00:00,215640000.0,GENESYS.NS
Operating Expense,2023-03-31 00:00:00,635101000.0,GENESYS.NS
Other Operating Expenses,2023-03-31 00:00:00,104733000.0,GENESYS.NS
Depreciation And Amortization In Income Statement,2023-03-31 00:00:00,372090000.0,GENESYS.NS
Amortization,2023-03-31 00:00:00,239704000.0,GENESYS.NS
Depreciation Income Statement,2023-03-31 00:00:00,132386000.0,GENESYS.NS
Selling General And Administration,2023-03-31 00:00:00,81610000.0,GENESYS.NS
General And Administrative Expense,2023-03-31 00:00:00,81610000.0,GENESYS.NS
Rent And Landing Fees,2023-03-31 00:00:00,3305000.0,GENESYS.NS
Gross Profit,2023-03-31 00:00:00,850741000.0,GENESYS.NS
Cost Of Revenue,2023-03-31 00:00:00,960544000.0,GENESYS.NS
Total Revenue,2023-03-31 00:00:00,1811285000.0,GENESYS.NS
Operating Revenue,2023-03-31 00:00:00,1811285000.0,GENESYS.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,-134949600.0,GENESYS.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.3,GENESYS.NS
Normalized EBITDA,2022-03-31 00:00:00,307180000.0,GENESYS.NS
Total Unusual Items,2022-03-31 00:00:00,-449832000.0,GENESYS.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,-449832000.0,GENESYS.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,134115000.0,GENESYS.NS
Reconciled Depreciation,2022-03-31 00:00:00,191257000.0,GENESYS.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,806680000.0,GENESYS.NS
EBITDA,2022-03-31 00:00:00,-142652000.0,GENESYS.NS
EBIT,2022-03-31 00:00:00,-333909000.0,GENESYS.NS
Net Interest Income,2022-03-31 00:00:00,-22994000.0,GENESYS.NS
Interest Expense,2022-03-31 00:00:00,24776000.0,GENESYS.NS
Interest Income,2022-03-31 00:00:00,3083000.0,GENESYS.NS
Normalized Income,2022-03-31 00:00:00,448997400.0,GENESYS.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,134115000.0,GENESYS.NS
Total Expenses,2022-03-31 00:00:00,1072671000.0,GENESYS.NS
Rent Expense Supplemental,2022-03-31 00:00:00,6534000.0,GENESYS.NS
Diluted Average Shares,2022-03-31 00:00:00,33704335.0,GENESYS.NS
Basic Average Shares,2022-03-31 00:00:00,31247559.0,GENESYS.NS
Diluted EPS,2022-03-31 00:00:00,4.13,GENESYS.NS
Basic EPS,2022-03-31 00:00:00,4.28,GENESYS.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,134115000.0,GENESYS.NS
Net Income Common Stockholders,2022-03-31 00:00:00,134115000.0,GENESYS.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,GENESYS.NS
Net Income,2022-03-31 00:00:00,134115000.0,GENESYS.NS
Minority Interests,2022-03-31 00:00:00,530969000.0,GENESYS.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,-396854000.0,GENESYS.NS
Net Income Continuous Operations,2022-03-31 00:00:00,-396854000.0,GENESYS.NS
Tax Provision,2022-03-31 00:00:00,38169000.0,GENESYS.NS
Pretax Income,2022-03-31 00:00:00,-358685000.0,GENESYS.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,7130000.0,GENESYS.NS
Special Income Charges,2022-03-31 00:00:00,-451068000.0,GENESYS.NS
Other Special Charges,2022-03-31 00:00:00,451068000.0,GENESYS.NS
Write Off,2022-03-31 00:00:00,0.0,GENESYS.NS
Impairment Of Capital Assets,2022-03-31 00:00:00,0.0,GENESYS.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-22994000.0,GENESYS.NS
Total Other Finance Cost,2022-03-31 00:00:00,1301000.0,GENESYS.NS
Interest Expense Non Operating,2022-03-31 00:00:00,24776000.0,GENESYS.NS
Interest Income Non Operating,2022-03-31 00:00:00,3083000.0,GENESYS.NS
Operating Income,2022-03-31 00:00:00,92432000.0,GENESYS.NS
Operating Expense,2022-03-31 00:00:00,265991000.0,GENESYS.NS
Other Operating Expenses,2022-03-31 00:00:00,62429000.0,GENESYS.NS
Depreciation And Amortization In Income Statement,2022-03-31 00:00:00,191256000.0,GENESYS.NS
Amortization,2022-03-31 00:00:00,,GENESYS.NS
Depreciation Income Statement,2022-03-31 00:00:00,191256000.0,GENESYS.NS
Selling General And Administration,2022-03-31 00:00:00,36961000.0,GENESYS.NS
General And Administrative Expense,2022-03-31 00:00:00,36961000.0,GENESYS.NS
Rent And Landing Fees,2022-03-31 00:00:00,6534000.0,GENESYS.NS
Gross Profit,2022-03-31 00:00:00,358423000.0,GENESYS.NS
Cost Of Revenue,2022-03-31 00:00:00,806680000.0,GENESYS.NS
Total Revenue,2022-03-31 00:00:00,1165103000.0,GENESYS.NS
Operating Revenue,2022-03-31 00:00:00,1165103000.0,GENESYS.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,GENESYS.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,GENESYS.NS
Normalized EBITDA,2021-03-31 00:00:00,,GENESYS.NS
Total Unusual Items,2021-03-31 00:00:00,-323986000.0,GENESYS.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,-323986000.0,GENESYS.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,GENESYS.NS
Reconciled Depreciation,2021-03-31 00:00:00,,GENESYS.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,GENESYS.NS
EBITDA,2021-03-31 00:00:00,,GENESYS.NS
EBIT,2021-03-31 00:00:00,,GENESYS.NS
Net Interest Income,2021-03-31 00:00:00,,GENESYS.NS
Interest Expense,2021-03-31 00:00:00,,GENESYS.NS
Interest Income,2021-03-31 00:00:00,1616000.0,GENESYS.NS
Normalized Income,2021-03-31 00:00:00,,GENESYS.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,GENESYS.NS
Total Expenses,2021-03-31 00:00:00,,GENESYS.NS
Rent Expense Supplemental,2021-03-31 00:00:00,8687000.0,GENESYS.NS
Diluted Average Shares,2021-03-31 00:00:00,,GENESYS.NS
Basic Average Shares,2021-03-31 00:00:00,,GENESYS.NS
Diluted EPS,2021-03-31 00:00:00,,GENESYS.NS
Basic EPS,2021-03-31 00:00:00,,GENESYS.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,GENESYS.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,GENESYS.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,GENESYS.NS
Net Income,2021-03-31 00:00:00,,GENESYS.NS
Minority Interests,2021-03-31 00:00:00,,GENESYS.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,GENESYS.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,GENESYS.NS
Tax Provision,2021-03-31 00:00:00,,GENESYS.NS
Pretax Income,2021-03-31 00:00:00,,GENESYS.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,GENESYS.NS
Special Income Charges,2021-03-31 00:00:00,-327937000.0,GENESYS.NS
Other Special Charges,2021-03-31 00:00:00,311573000.0,GENESYS.NS
Write Off,2021-03-31 00:00:00,1988000.0,GENESYS.NS
Impairment Of Capital Assets,2021-03-31 00:00:00,16364000.0,GENESYS.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,GENESYS.NS
Total Other Finance Cost,2021-03-31 00:00:00,8059000.0,GENESYS.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,GENESYS.NS
Interest Income Non Operating,2021-03-31 00:00:00,1616000.0,GENESYS.NS
Operating Income,2021-03-31 00:00:00,,GENESYS.NS
Operating Expense,2021-03-31 00:00:00,,GENESYS.NS
Other Operating Expenses,2021-03-31 00:00:00,,GENESYS.NS
Depreciation And Amortization In Income Statement,2021-03-31 00:00:00,,GENESYS.NS
Amortization,2021-03-31 00:00:00,,GENESYS.NS
Depreciation Income Statement,2021-03-31 00:00:00,,GENESYS.NS
Selling General And Administration,2021-03-31 00:00:00,29990000.0,GENESYS.NS
General And Administrative Expense,2021-03-31 00:00:00,29990000.0,GENESYS.NS
Rent And Landing Fees,2021-03-31 00:00:00,8687000.0,GENESYS.NS
Gross Profit,2021-03-31 00:00:00,,GENESYS.NS
Cost Of Revenue,2021-03-31 00:00:00,,GENESYS.NS
Total Revenue,2021-03-31 00:00:00,,GENESYS.NS
Operating Revenue,2021-03-31 00:00:00,,GENESYS.NS
